8-K

                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C.  20549

                                   FORM 8-K

                                CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported):  August 7, 2001

                               DRUGMAX.COM, INC.
            (Exact name of registrant as specified in its charter)

      STATE OF NEVADA                   1-15445                  34-1755390
(State or other jurisdiction     (Commission File Number)       (IRS Employer
     of incorporation)                                       Identification No.)

                          12505 STARKEY ROAD, SUITE A
                             Largo, Florida  33773
                   (Address of principal executive offices)

      Registrant's telephone number, including area code:  (727) 533-0431


ITEM 5.    OTHER EVENTS.

   On August 7, 2001, DrugMax.com, Inc. (the "Company") issued a press release
announcing its financial results for the first quarter ended June 30, 2001. A
copy of the press release, which is incorporated by reference herein and made a
part hereof, is filed with this Current Report on Form 8-K as Exhibit 99.


ITEM 7.    FINANCIAL STATEMENTS AND EXHIBITS.

   (a) Financial Statements of Business.

       None.

   (b) Pro Forma Financial Information.

       None.

   (c) Exhibits.

  Exhibit
  Number         Exhibit Description
  -------        -------------------
   99.1          Press Release, dated August 7, 2001.



                                   SIGNATURE
                                   ---------

     Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the Registrant has duly caused this Report to be signed on its behalf
by the undersigned thereunto duly authorized.



                                DRUGMAX.COM, INC.

                                By:  /s/ William L. LaGamba
                                     ------------------------------------
                                     William L. LaGamba, Chief Operations
                                        Officer and President



Dated: August 7, 2001



                                 EXHIBIT INDEX


Exhibit
Number        Exhibit Description
- ------        -------------------

 99.1         Press Release, dated August 7, 2001

EX-99.1

                                                                    EXHIBIT 99.1

                                                            [DrugMax Letterhead]


Company Media/IR Contact:
DrugMax.com
Eli Johnson
727.533.0431
ejohnson@DrugMax.com

                      DrugMax.com, Inc. Announces Record
                        First Quarter Financial Results

LARGO, Fla.  - August 7, 2001 -- DrugMax.com, Inc. (NASDAQ: DMAX) a full-line
wholesale distributor of pharmaceuticals, over-the-counter products, health and
beauty aids and nutritional supplements, today announced financial results for
the first quarter ended June 30, 2001.

Revenues were $70.9 million for the first quarter ended June 30, 2001, a 146.2
percent increase compared to $28.8 million for the same quarter last year.

Earnings per diluted share were $.12 for the first quarter ended June 30, 2001
compared to a loss of $.24 per share for the same quarter last year.
DrugMax.com has adopted the Financial Accounting Standards Board (FASB)
Statement No. 142, "Goodwill and Other Intangible Assets", effective for the
first quarter ended June 30, 2001.  Beginning this quarter, DrugMax.com will no
longer amortize goodwill associated with acquisitions.  This had an effect of
adding approximately $.06 per diluted share to the quarter ended June 30, 2001.
In addition, DrugMax.com realized a portion of their deferred tax asset from
fiscal year ended March 31, 2001, which added approximately $.07 per diluted
share to the Company's first quarter results.  Management believes it is more
likely than not that the deferred tax assets will be utilized due to the
generation of taxable income.

"We are extremely proud of our financial results and our growth in net revenues
of our core business," Ron Patrick, Chief Financial Officer, said.  "The results
of increases in both net revenues and operating income continue to be ahead of
management's projections.  Operating income amounted to $627,000 for the quarter
ended June 30, 2001, compared to an operating loss of $704,000 for the quarter
ended June 30, 2000 after giving effect to the discontinued write off of
goodwill."

"Maximizing the returns on investments for our stockholders continues to be one
of our primary goals," Bill LaGamba, President and Chief Operating Officer,
said. "Based on the Company's results and the growth of the pharmaceutical
industry, we are very excited about our prospects for the future. Management is
confident that if we continue to focus on providing quality products and
services, developing mutually beneficial relationships with our expanding
customer base and keeping operational expenses down, then we can continue to
improve the long-term financial stability of DrugMax."

About DrugMax.com, Inc.


DrugMax.com, Inc. (the "Company") is primarily a full-line, wholesale
distributor of pharmaceuticals, over-the-counter products, health and beauty
care products, and nutritional supplements. The Company expects that it will
continue to derive a significant portion of its revenue from its traditional
"brick and mortar" full-line wholesale distribution business.  However, the
Company is also one of the early entrants into the Internet business-to-business
pharmaceutical market and one of the first business-to-business online trade
exchanges for the same products.  The Company utilizes its online capabilities
to leverage its existing infrastructure, technology, relationships, marketing
and management resources and, accordingly, believes that the combination of its
traditional wholesale distribution business with both its online wholesale
distribution business and its e-commerce trade exchange provides the "click and
mortar" combination that allows it to aggressively market and distribute its
products and services.  The Company can be reached at www.drugmax.com, or 727-
                                                      ---------------
533-0431.

Safe Harbor Provisions

     Certain oral statements made by management from time to time and certain
statements contained herein that are not historical facts are "forward-looking
statements" within the meaning of Section 21E of the Securities Exchange Act of
1934 and, because such statements involve risks and uncertainties, actual
results may differ materially from those expressed or implied by such forward-
looking statements.  Forward-looking statements are statements regarding the
intent, belief or current expectations, estimates or projections of the Company,
its directors or its officers about the Company and the industry in which it
operates, and are based on assumptions made by management.  Forward-looking
statements include without limitation statements regarding: (a) the Company's
strategies regarding growth and business expansion, including future
acquisitions; (b) the Company's financing plans; (c) trends affecting the
Company's financial condition or results of operations; (d) the Company's
ability to continue to control costs and to meet its liquidity and other
financing needs; (e) the declaration and payment of dividends; (f) the Company's
use of proceeds from the currently contemplated equity offering, and (g) the
Company's ability to respond to changes in customer demand and regulations.
Although the Company believes that its expectations are based on reasonable
assumptions, it can give no assurance that the anticipated results will occur.
When used in this report, the words "expects," "anticipates," intends," "plans,"
"believes," "seeks," "estimates," and similar expressions are generally intended
to identify forward-looking statements.

     Important factors that could cause the actual results to differ materially
from those in the forward-looking statements include, among other items, (i)
changes in the regulatory and general economic environment related to the health
care industry; (ii) conditions in the capital markets, including the interest
rate environment and the availability of capital; (iii) changes in the
competitive marketplace that could affect the Company's revenue and/or cost and
expenses, such as increased competition, lack of qualified marketing, management
or other personnel, and increased labor and inventory costs; (iv) changes in
technology or customer requirements, which could render the Company's
technologies noncompetitive or obsolete; (v) new product introductions, product
sales mix and the geographic mix of sales and (vi) the Company's customers'
willingness to accept its Internet platform. Further information relating to
factors that could cause actual results to differ from those anticipated is
included but not limited to information under the headings "Management's
Discussion and Analysis of Financial Conditions and Results of Operations,"
"Business" and "Risk Factors" in the Company's Form 10-KSB for the year ended
March 31, 2001. The Company disclaims any intention or obligation to update or
revise forward-looking statements, whether as a result of new information,
future events or otherwise.